Streetbeat News

Products Services

JBLU

JSX, backed by JetBlue Airways (NASDAQ:JBLU), has placed an order for up to 332 hybrid-electric aircraft from various manufacturers, with deliveries starting in 2028. The order includes the Heart Aerospace ES-30, Aura Aero Era, and Electra eSTOL aircraft. JSX aims to serve over 2000 airports, reducing travel costs and carbon emissions. The confirmed order is for 132 aircraft, with the rest as options.

Portfolio Pulse from Anan Ashraf

December 20, 2023 | 12:46 pm

PTN

Palatin Technologies has sold Vyleesi, an FDA-approved treatment for premenopausal women with Hypoactive Sexual Desire Disorder, to Cosette Pharmaceuticals for up to $171 million. The deal includes a $12 million upfront payment and up to $159 million in sales-based milestones. Palatin will now focus on its melanocortin receptor system-based development and clinical pipeline.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:42 pm

ABSI

Absci Corporation (ABSI) has partnered with PrecisionLife to develop a joint portfolio of AI-enabled drug pipeline projects. The collaboration aims to discover and develop biotherapeutics for up to five targets and indications, focusing on chronic diseases with unmet clinical needs. Both companies will share in the potential value of the programs developed.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:33 pm

INKT

MiNK Therapeutics has entered into a collaboration with ImmunoScape to accelerate the identification of novel TCRs and the development of TCR-based therapeutics. This partnership aims to enhance MiNK's pipeline of TCR therapeutics for cancer and other diseases. ImmunoScape's deep immunomics platform will be utilized to identify and analyze TCRs, potentially leading to more effective treatments.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:32 pm

AIRE

CAMP

CMTL

LIDR

The article highlights four oversold tech stocks with potential for growth in Q4, based on their low Relative Strength Index (RSI) values. Comtech Telecommunications Corp. (CMTL) reported mixed Q1 results with a significant stock price drop and an RSI of 26.21. reAlpha Tech Corp. (AIRE) signed an intent to acquire United Software Group, with a 68% stock price drop and an RSI of 3.25. CalAmp Corp. (CAMP) reported a Q2 revenue miss, a 45% stock price drop, and an RSI of 24.31. AEye, Inc. (LIDR) was informed by Continental of discontinuing their joint lidar development program, leading to a 41% stock price drop in five days and an RSI of 13.38.

Portfolio Pulse from Avi Kapoor

December 20, 2023 | 12:28 pm

PRZO

ParaZero Technologies Ltd. (NASDAQ:PRZO) has announced the successful completion of a drone safety solution for a Fortune 500 automotive manufacturer's proprietary drone program. The project involved the development of a custom variant of ParaZero's SafeAir™ drone safety system, for which the company has received full payment.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:18 pm

DNA

OneOne Biosciences has entered into a partnership with Ginkgo Bioworks to further develop its platform and advance its nitrogen fixation microbial product. This collaboration aims to enhance OneOne Biosciences' capabilities in creating sustainable agricultural solutions.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:08 pm

TECH

Bio-Techne has submitted a Drug Master File to the FDA for its ExCellerate GMP iPSC Expansion Medium, which is designed to support stem cell therapy. This submission is a significant step for Bio-Techne as it aims to facilitate the development and commercialization of stem cell therapies, potentially accelerating the availability of these treatments to patients.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:06 pm

TAK

Takeda Pharmaceutical Company has secured a two-year contract with Canadian Blood Services for the supply of GLASSIA, a treatment for a rare form of emphysema. This deal may positively impact Takeda's revenues and market presence in Canada.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:04 pm

NSPR

InspireMD has announced the issuance of a key U.S. patent for its SwitchGuard Neuroprotection System, which is designed to protect against embolic events during stenting procedures. This patent strengthens the company's intellectual property portfolio and may enhance its competitive position in the market for neuroprotection devices.

Portfolio Pulse from Benzinga Newsdesk

December 20, 2023 | 12:02 pm